Double blind design is one which neither the subject nor the researcher knows the research status of the subject. This therefore reduces the assesment bias. The use of placebo ensures that the subjects belonging to the control group receive a placebo which is pharmacologically inactive treatment, as if it were an active and therefore this reduces the response bias also called as placebo effect. The knowledge that the person is being treated may alter the patient’s response to treatment.